BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 11:47:00 AM | Browse: 963 | Download: 862
Publication Name World Journal of Gastroenterology
Manuscript ID 5611
Country Italy
Received
2013-09-17 11:34
Peer-Review Started
2013-09-17 17:57
To Make the First Decision
2013-10-14 21:28
Return for Revision
2013-10-20 17:10
Revised
2013-11-07 16:05
Second Decision
2013-12-03 21:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-12-04 06:32
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-12-30 11:14
Publish the Manuscript Online
2014-02-19 16:57
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Eradication of Helicobacter pylori infection: Which regimen first?
Manuscript Source Invited Manuscript
All Author List Alessandro Federico, Antonietta Gerarda Gravina, Agnese Miranda, Carmela Loguercio and Marco Romano
Funding Agency and Grant Number
Corresponding Author Marco Romano, MD, Department of Clinical and Experimental Medicine, Gastroenterology Unit, Second University of Naples, Via Pansini 5, 80131 Naples, Italy. marco.romano@unina2.it
Key Words Helicobacter pylori; Sequential therapy; Hybrid therapy; Concomitant therapy; Clarithromycin; Levofloxacin
Core Tip First-line therapy for Helicobacter pylori infection should have an efficacy higher than 90% to prevent the need for additional treatment and the emergence of secondary antimicrobial resistance. The first-line eradication regimen should be based on what works best in a defined geographical area and must take into account the prevalence of antimicrobial resistance in that region. Non-bismuth quadruple (i.e., concomitant) therapy appears to have high efficacy and, in our opinion, is the first choice of treatment for eradicating the infection.
Publish Date 2014-02-19 16:57
Citation Federico A, Gravina AG, Miranda A, Loguercio C, Romano M. Eradication of Helicobacter pylori infection: Which regimen first? World J Gastroenterol 2014; 20(3): 665-672
URL http://www.wjgnet.com/1007-9327/full/v20/i3/665.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i3.665
Full Article (PDF) WJG-20-665.pdf
Full Article (Word) WJG-20-665.doc
Manuscript File 5611-Review.doc
Answering Reviewers 5611-Answering reviewers.pdf
Copyright License Agreement 5611-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5611-Language certificate.pdf
Peer-review Report 5611-Peer reviewer(s).pdf
Scientific Editor Work List 5611-Scientific editor work list.doc